Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

360 Haoyao

Request full access

360 Haoyao is an online pharmacy marketplace

Huangpu, ChinaFounded 2013Biotech & Life Sciences

About 360 Haoyao

360 Haoyao, operating under the umbrella of 360 Health, marks a significant venture into China's burgeoning e-health market. The platform was launched in October 2015 by Guangzhou Youyi Information Technology Co., Ltd. and is spearheaded by Chen Hua, the former CEO of 1-Click-Pharmacy (1yaowang). Chen Hua's transition from a major online pharmacy to lead 360 Health underscores a strategic move to leverage his deep industry expertise in a new entrepreneurial context. The company secured a substantial Series A funding round of 100 million yuan (approximately $15.2 million) in May 2016, with Lilly Asia Ventures and SBCVC (SoftBank China Capital) as the lead investors. This investment, completed less than six months after the company's inception, highlights strong investor confidence in its business model and leadership.

360 Haoyao functions primarily as an open, third-party platform for pharmaceutical e-commerce, connecting consumers with a multitude of online drugstores. Rather than selling products directly, it serves as a comprehensive guide and search portal for consumers, aggregating offerings from partners like Jianke, Kangaiduo, and Laobaixing Online Pharmacy. The platform's revenue model is likely based on commissions, service fees, or a combination thereof from its partnered vendors. The product catalog is extensive, featuring everyday medicines, medical devices, health supplements, personal care items, and mother-and-baby products.

Beyond its consumer-facing marketplace, 360 Health has developed a robust technology-as-a-service arm for the pharmaceutical industry. It offers a technology cloud platform with two main products: "Tianji" and "Weizhan". Tianji is a specialized warehouse and supply chain management system designed for pharmaceutical e-commerce, encompassing ERP, WMS, and OMS modules. It provides these services to established pharmaceutical companies like Tongrentang, helping them digitize and streamline their operations. "Weizhan" is a cloud-based member service platform that equips pharmaceutical manufacturers with tools for fan management and distribution, aiming to enhance customer loyalty. This dual-platform strategy addresses two critical pain points for the industry: technology infrastructure and customer traffic, positioning 360 Health as a comprehensive service provider in the digital health sector.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
19.7/100
Industry
Health, Security
Sub-industry
BioTechnology, Public safety
Sector
Real Estate, Consumer Electronics, Biotechnology, Smart Home, Biotech and Pharma, Hard Tech
Business model
Marketplace & ecommerce
Client focus
B2B
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2016 $15M $61M SB China Capital · Lilly Asia Ventures —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

360 Haoyao website traffic

Latest recorded traffic for 360 Haoyao is 30 monthly website visits, down 99.2% over the last three months.

Latest monthly visits30 3-month web change-99.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

360 Haoyao in the Huangpu ecosystem

Live from Dealroom

The 360 Haoyao office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • SB China Capital
  • Lilly Asia Ventures
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Huangpu HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about 360 Haoyao on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See 360 Haoyao’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.